IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,113,986 | +42.6% | 216,868 | +16.6% | 0.71% | +13.5% |
Q1 2023 | $2,885,558 | +2.9% | 186,045 | +17.7% | 0.63% | -15.9% |
Q4 2022 | $2,804,607 | -0.1% | 158,006 | +160.0% | 0.75% | +3.9% |
Q4 2020 | $2,807,000 | -46.9% | 60,781 | -59.5% | 0.72% | -48.6% |
Q3 2020 | $5,284,000 | +73.4% | 150,151 | +20.0% | 1.40% | +63.1% |
Q2 2020 | $3,047,000 | +387.5% | 125,125 | +211.8% | 0.86% | +195.9% |
Q1 2020 | $625,000 | – | 40,125 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |